Writing on product systems, fintech infrastructure, market behavior, and leadership lessons from practical execution.
📚 Books
Beyond platform leadership and infrastructure design, I write about trading psychology, financial literacy, and structured market participation.
Both books are published globally on Amazon (Kindle & Paperback editions available).
🟦 The Mind Game of Trading
Mastering Psychology for Consistent Profits
By Sreenivasulu Malkari

Overview
Trading success is rarely limited by strategy. It is limited by psychology.
In The Mind Game of Trading, I distill 15+ years of real-world trading experience into a structured framework for mastering discipline, emotional control, and execution integrity.
The book focuses on:
• Identifying hidden cognitive biases
• Structured journaling & checklist systems
• Emotional risk management
• Practical trading plan templates
• Long-term consistency frameworks
This is not a theory book — it is a practical discipline manual for traders at all levels.
🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FNKGB7W2
🟦 The Stock Market Starter Kit
Learn to Trade Smart in 7 Days
By Sreenivasulu Malkari

Overview
Designed for beginners entering the Indian stock market, this book simplifies complex concepts into a structured 7-day learning framework.
It emphasizes structured thinking, capital protection, and long-term consistency as the core pillars of intelligent market participation.
It covers:
• How stock markets function (NSE/BSE context)
• Intraday, swing & long-term trading basics
• Risk management principles
• Chart reading fundamentals
• Practical checklists and action plans
Clear. Structured. Actionable.
🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FF2NK8MV
-
Laurus Labs Downplays Impact of New US Pharma Tariffs on Branded Drugs
Laurus Labs Ltd. does not anticipate any significant implications of the US tariff of 100% on branded or patented pharmaceutical products, according to a top executive.
-
Indian Stock Market Today: Nifty, Sensex Record Worst Week In Nearly Eight Months
The Nifty 50 and Sensex ended lower for six sessions in a row, posting the worst week since March. Get the latest updates and analysis on the Indian stock market.
-
Poly Medicure’s Italy-Based Citieffe Acquisition: A Strategic Move to Dominate Medical Device Space
Poly Medicure’s recent acquisition of Italy-based Citieffe Group is a strategic move to strengthen its presence in the high-value medical device space. Here’s what it means for Indian investors and the company’s future prospects.
-
Welspun Corp Ltd Sees Significant Boost in Global Order Book
Welspun Corp Ltd has received a fresh order worth Rs 1,600 crore from the Middle East, taking its global order book to nearly Rs 18,000 crore. What does this mean for Indian investors?
-
Sensex Hits Three-Week Low, Nifty Below 24,700: Are Small and Mid Caps Buying Opportunities?
The Indian stock market witnessed a significant decline on Friday, with the Sensex and Nifty hitting three-week lows. We explore the reasons behind this downturn and examine if small and mid caps offer buying opportunities for investors.
-
Trump’s Pharma Tariff: A Double-Edged Sword for Indian Drugmakers and US Consumers
US President Donald Trump’s announcement of a 100% tariff on branded and patented pharmaceutical drugs may have far-reaching consequences for Indian drugmakers and US consumers alike.